From: Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
Variable | Mean ± SD and Median [IQR] |
---|---|
Number of enrolled patients | 27 |
Sex (Male/Female) | 18/9 |
Etiology of end-stage renal disease | Diabetic nephropathy, 12 patients |
Nephrosclerosis, 6 patients | |
CGN, 6 patients | |
ADPKD, 2 patients | |
Graft loss, 1 patient | |
Age (year) | 70 ± 13, 75 [57, 80] |
Dialysis duration (year) | 8 ± 9, 6 [1,11] |
Dry weight (kg) | 58.1 ± 13.3, 58.1 [53.7, 61.5] |
Single pool Kt/V | 1.08 ± 0.25, 1.11 [0.86, 1.30] |
Concomitant laxative | 1 type drug: 13 patients |
2 types drugs: 10 patients | |
3 types drugs: 4 patients | |
Type of concomitant laxative | Sennosides A and B, 26 patients |
Sodium picosulfate hydrate, 5 patients | |
Glycerine enema, 1 patient | |
Lactulose, 2 patients | |
Sodium dihydrogen phosphate/sodium hydrogen carbonate, 2 patients | |
Lubiprostone, 5 patients | |
Lactomin, 3 patients | |
Daikenchuto, 1 patient | |
Phosphate binder | 0 drug, 3 patients |
1 type of drug, 15 patients | |
2 types of drug, 9 patients | |
Type of phosphate binder | Lantern carbonate, 6 patients |
Calcium carbonate, 19 patients | |
Ferric citrate, 6 patients | |
Sucroferric oxyhydroxide, 2 patients |